C
Christiane Piepel
Publications - 5
Citations - 155
Christiane Piepel is an academic researcher. The author has contributed to research in topics: Cohort study & Medicine. The author has an hindex of 2, co-authored 5 publications receiving 44 citations.
Papers
More filters
Journal ArticleDOI
COVID-19 in cancer patients: clinical characteristics and outcome-an analysis of the LEOSS registry
Maria Rüthrich,C. Giessen-Jung,Stefan Borgmann,Annika Y. Classen,Sebastian Dolff,Beate Grüner,Frank Hanses,Nora Isberner,Philipp Köhler,Julia Lanznaster,Uta Merle,Silvio Nadalin,Christiane Piepel,J. Schneider,J. Schneider,M. Schons,R. Strauss,Lukas Tometten,Jorg-Janne Vehreschild,Jorg-Janne Vehreschild,M. von Lilienfeld-Toal,Gernot Beutel,Kai Wille +22 more
TL;DR: In this paper, the authors present an analysis of cancer patients from the LEOSS (Lean European Open Survey on SARS-CoV-2 Infected Patients) registry to determine whether cancer patients are at higher risk.
Journal ArticleDOI
Neurological symptoms and complications in predominantly hospitalized COVID-19 patients: Results of the European multinational Lean European Open Survey on SARS-Infected Patients (LEOSS).
Nina N. Kleineberg,Nina N. Kleineberg,Samuel Knauss,Eileen Gülke,Hans O. Pinnschmidt,Carolin Jakob,Paul Lingor,Kerstin Hellwig,Achim Berthele,Günter U. Höglinger,Günter U. Höglinger,Gereon R. Fink,Gereon R. Fink,Matthias Endres,Christian Gerloff,Christine Klein,Melanie Stecher,Annika Y. Classen,Siegbert Rieg,Stefan Borgmann,Frank Hanses,Maria Rüthrich,Martin Hower,Lukas Tometten,Martina Haselberger,Christiane Piepel,Uta Merle,Sebastian Dolff,Christian Degenhardt,Björn-Erik Ole Jensen,Maria J G T Vehreschild,Johanna Erber,Christiana Franke,Clemens Warnke +33 more
TL;DR: In this paper, the effects of prior neurological diseases and the effect of neurological symptoms on outcome were studied using multivariate logistic regression using real-world data from a multinational registry.
Journal ArticleDOI
Gastrointestinal bleeding and endoscopic findings in critically and non-critically ill patients with corona virus disease 2019 (COVID-19): Results from Lean European Open Survey on SARS-CoV-2 (LEOSS) and COKA registries.
Stephan Zellmer,Frank Hanses,Anna Muzalyova,Johanna Classen,Georg Braun,Christiane Piepel,Johanna Erber,Lisa Pilgram,Lorenz Walter,Siri Göpel,Kai Wille,Martin Hower,Maria Rüthrich,Jan Rupp,Christian Degenhardt,Ingo Voigt,Stefan Borgmann,Melanie Stecher,Carolin Jakob,Christine Dhillon,Helmut Messmann,Alanna Ebigbo,Christoph Römmele +22 more
TL;DR: In this article, the authors examined the association between occurrence of GI bleeding and comorbidities as well as medication and found that the use of therapeutic anticoagulants showed a significant association with the increased incidence of bleeding in the critical phase of disease.
Journal ArticleDOI
Outcomes of SARS-CoV-2 Infections in Patients with Neurodegenerative Diseases in the LEOSS Cohort.
Meret K. Huber,Claudia Raichle,Paul Lingor,Paul Lingor,Matthis Synofzik,Matthis Synofzik,Stefan Borgmann,Johanna Erber,Lukas Tometten,Wolfgang Rimili,Sebastian Dolff,Kai Wille,Samuel Knauss,Christiane Piepel,Julia Lanznaster,Siegbert Rieg,Fabian Prasser,Lisa Pilgram,Annika Spottke,Annika Spottke,Thomas Klockgether,Thomas Klockgether,Christine Klein,Franziska Hopfner,Günter U. Höglinger,Günter U. Höglinger +25 more
Journal ArticleDOI
Angiotensin II receptor blocker intake associates with reduced markers of inflammatory activation and decreased mortality in patients with cardiovascular comorbidities and COVID-19 disease.
Sebastian Cremer,Lisa Pilgram,Alexander Berkowitsch,Melanie Stecher,Siegbert Rieg,Mariana Shumliakivska,Denisa Bojkova,Julian U. G. Wagner,Galip Servet Aslan,Christoph D. Spinner,Guillermo Luxán,Frank Hanses,Sebastian Dolff,Christiane Piepel,Clemens Ruppert,Andreas Guenther,Maria Madeleine Rüthrich,Jörg J. Vehreschild,Kai Wille,Martina Haselberger,Hanno Heuzeroth,Arne Hansen,Thomas Eschenhagen,Jindrich Cinatl,Sandra Ciesek,Stefanie Dimmeler,Stefan Borgmann,Andreas M. Zeiher +27 more
TL;DR: In this paper, the authors show that angiotensin II receptor blocker intake is associated with decreased mortality in patients with COVID-19 [OR 0.75 (95% CI 0,59-0.96; p = 0.013)].